BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14607941)

  • 1. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection.
    Dockrell DH; Marriott HM; Prince LR; Ridger VC; Ince PG; Hellewell PG; Whyte MK
    J Immunol; 2003 Nov; 171(10):5380-8. PubMed ID: 14607941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia.
    Marriott HM; Hellewell PG; Cross SS; Ince PG; Whyte MK; Dockrell DH
    J Immunol; 2006 Nov; 177(9):6480-8. PubMed ID: 17056580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.
    Camberlein E; Cohen JM; José R; Hyams CJ; Callard R; Chimalapati S; Yuste J; Edwards LA; Marshall H; van Rooijen N; Noursadeghi M; Brown JS
    Infect Immun; 2015 Mar; 83(3):1181-9. PubMed ID: 25583525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.
    Knapp S; Wieland CW; van 't Veer C; Takeuchi O; Akira S; Florquin S; van der Poll T
    J Immunol; 2004 Mar; 172(5):3132-8. PubMed ID: 14978119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.
    Stolberg VR; McCubbrey AL; Freeman CM; Brown JP; Crudgington SW; Taitano SH; Saxton BL; Mancuso P; Curtis JL
    J Immunol; 2015 Jul; 195(1):174-84. PubMed ID: 25987742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout mice.
    Dolan JM; Weinberg JB; O'Brien E; Abashian A; Procario MC; Aronoff DM; Crofford LJ; Peters-Golden M; Ward L; Mancuso P
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1111-20. PubMed ID: 27059285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.
    Arredouani M; Yang Z; Ning Y; Qin G; Soininen R; Tryggvason K; Kobzik L
    J Exp Med; 2004 Jul; 200(2):267-72. PubMed ID: 15263032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling.
    Wang J; Barke RA; Charboneau R; Schwendener R; Roy S
    J Immunol; 2008 Mar; 180(5):3594-600. PubMed ID: 18292587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia.
    Schabbauer G; Matt U; Günzl P; Warszawska J; Furtner T; Hainzl E; Elbau I; Mesteri I; Doninger B; Binder BR; Knapp S
    J Immunol; 2010 Jul; 185(1):468-76. PubMed ID: 20505137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.
    Yang Z; Chiou TT; Stossel TP; Kobzik L
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia.
    Tabeling C; Wienhold SM; Birnhuber A; Brack MC; Nouailles G; Kershaw O; Firsching TC; Gruber AD; Lienau J; Marsh LM; Olschewski A; Kwapiszewska G; Witzenrath M
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L916-L925. PubMed ID: 33655757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia.
    Sharif O; Gawish R; Warszawska JM; Martins R; Lakovits K; Hladik A; Doninger B; Brunner J; Korosec A; Schwarzenbacher RE; Berg T; Kralovics R; Colinge J; Mesteri I; Gilfillan S; Salmaggi A; Verschoor A; Colonna M; Knapp S
    PLoS Pathog; 2014 Jun; 10(6):e1004167. PubMed ID: 24945405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia.
    Walker MM; Novak L; Widener R; Grubbs JA; King J; Hale JY; Ochs MM; Myers LE; Briles DE; Deshane J
    J Immunol; 2016 Mar; 196(5):2239-48. PubMed ID: 26829988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of Pneumococci to Activate Macrophage Nuclear Factor κB: Influence on Necroptosis and Pneumonia Severity.
    Coleman FT; Blahna MT; Kamata H; Yamamoto K; Zabinski MC; Kramnik I; Wilson AA; Kotton DN; Quinton LJ; Jones MR; Pelton SI; Mizgerd JP
    J Infect Dis; 2017 Aug; 216(4):425-435. PubMed ID: 28368460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.
    Schuijt TJ; Lankelma JM; Scicluna BP; de Sousa e Melo F; Roelofs JJ; de Boer JD; Hoogendijk AJ; de Beer R; de Vos A; Belzer C; de Vos WM; van der Poll T; Wiersinga WJ
    Gut; 2016 Apr; 65(4):575-83. PubMed ID: 26511795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting roles for reactive oxygen species and nitric oxide in the innate response to pulmonary infection with Streptococcus pneumoniae.
    Marriott HM; Hellewell PG; Whyte MK; Dockrell DH
    Vaccine; 2007 Mar; 25(13):2485-90. PubMed ID: 17030496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia.
    Jounblat R; Clark H; Eggleton P; Hawgood S; Andrew PW; Kadioglu A
    Respir Res; 2005 Oct; 6(1):126. PubMed ID: 16255775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.
    Knapp S; Leemans JC; Florquin S; Branger J; Maris NA; Pater J; van Rooijen N; van der Poll T
    Am J Respir Crit Care Med; 2003 Jan; 167(2):171-9. PubMed ID: 12406830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia.
    Hommes TJ; van Lieshout MH; van 't Veer C; Florquin S; Bootsma HJ; Hermans PW; de Vos AF; van der Poll T
    PLoS One; 2015; 10(12):e0145138. PubMed ID: 26673231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage Turnover Kinetics in the Lungs of Mice Infected with Streptococcus pneumoniae.
    Taut K; Winter C; Briles DE; Paton JC; Christman JW; Maus R; Baumann R; Welte T; Maus UA
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):105-13. PubMed ID: 17690327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.